High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$796K
$796,999
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| DFTX |
Definium Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-25 | $451,241 | S | Form 4 |
|
DFTX
S
Definium Therapeutics, Inc.
Karlin Daniel
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-25
$148,092
|
||||||
| DFTX |
Definium Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-25 | $148,092 | S | Form 4 |
|
DFTX
S
Definium Therapeutics, Inc.
Sullivan Mark
• Officer • Chief Legal Officer
10b5-1 Sell
2026-03-25
$197,666
|
||||||
| DFTX |
Definium Therapeutics, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-03-25 | $197,666 | S | Form 4 |